Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The substrate selectivity of papain-like proteases from human-infecting coronaviruses correlates with innate immune suppression
Yuxian Xiong, Bin Huang, Ying Yang, et al.
Science Signaling (2023) Vol. 16, Iss. 783
Open Access | Times Cited: 12

Showing 12 citing articles:

SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 46
Bat genomes illuminate adaptations to viral tolerance and disease resistance
Ariadna E. Morales, Yue Dong, Tom Brown, et al.
Nature (2025)
Open Access | Times Cited: 5
Deubiquitinating activity of SARS-CoV-2 papain-like protease does not influence virus replication or innate immune responses in vivo
Mariska van Huizen, Jonna R. Bloeme - ter Horst, Heidi L.M. De Gruyter, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 3, pp. e1012100-e1012100
Open Access | Times Cited: 11
Differences and similarities between innate immune evasion strategies of human coronaviruses
Helene Hoenigsperger, Rinu Sivarajan, Konstantin M. J. Sparrer
Current Opinion in Microbiology (2024) Vol. 79, pp. 102466-102466
Open Access | Times Cited: 8
Design of quinoline SARS-CoV-2 papain-like protease inhibitors as oral antiviral drug candidates
Prakash D. Jadhav, Xueying Liang, Ahmadullah Ansari, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Anti-interferon armamentarium of human coronaviruses
Oyahida Khatun, Sumandeep Kaur, Shashank Tripathi
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID
Stefanie M. Bader, Dale J. Calleja, Shane M. Devine, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
The S1′–S3′ Pocket of the SARS‐CoV‐2 Main Protease Is Critical for Substrate Selectivity and Can Be Targeted with Covalent Inhibitors
Ming Liu, Jihui Li, Wenqi Liu, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 41
Open Access | Times Cited: 12
Targeting SARS-CoV-2 nonstructural protein 3: Function, structure, inhibition, and perspective in drug discovery
Xin Li, Yongcheng Song
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103832-103832
Open Access | Times Cited: 11
Viral deubiquitinating proteases and the promising strategies of their inhibition
Vera Jannie Elisabeth van Vliet, Anuradha De Silva, Brian L. Mark, et al.
Virus Research (2024) Vol. 344, pp. 199368-199368
Open Access | Times Cited: 3
The S1′–S3′ Pocket of the SARS‐CoV‐2 Main Protease Is Critical for Substrate Selectivity and Can Be Targeted with Covalent Inhibitors
Ming Liu, Jihui Li, Wenqi Liu, et al.
Angewandte Chemie (2023) Vol. 135, Iss. 41
Closed Access | Times Cited: 3
A cell-based Papain-like Protease (PLpro) activity assay for rapid detection of active SARS-CoV-2 infections and antivirals
Anahi G. Jimenez-Campos, Lucas I. Maestas, Nileena Velappan, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0309305-e0309305
Open Access
Page 1

Scroll to top